China Nepstar Sets IPO Terms

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China, has set its IPO terms to 20.6 million American despotory shares being offered at between $11.50 and $13.50 per share. It plans to trade on the NYSE under ticker symbol NPD, with Goldman Sachs (Asia) serving as lead underwriter. Goldman Sachs holds a 30.3% pre-IPO position.